{
    "clinical_study": {
        "@rank": "141266", 
        "acronym": "CENSER", 
        "arm_group": [
            {
                "arm_group_label": "Early norepinephrine", 
                "arm_group_type": "Active Comparator", 
                "description": "Norepinephrine 4 mg in 5% dextrose water 250 ml Intravenous infusion rate range from 8 to 15 ml/hour, adjusted according to patient's body weight to achieve norepinephrine 0.05microgram/kg/min Continuous drip for 48 hours."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "5% dextrose water 250 ml Intravenous infusion rate range from 8 to 15 ml/hour. Adjust rate of infusion according to patient's body weight to achieve dosage of norepinephrine comparable to 0.05 microgram/kg/min Continuous drip for 48 hours."
            }
        ], 
        "brief_summary": {
            "textblock": "Current septic shock guideline recommends fluid resuscitation as the first treatment.\n      Vasopressors, including norepinephrine is recommended to start after achieve adequate fluid\n      therapy. This can cause a certain duration of systemic hypotension before vasopressor is\n      commenced. Initiation of norepinephrine together with fluid therapy soon after diagnosis of\n      septic shock may increase blood pressure quicker than start treatment with intravenous fluid\n      alone. The rapid restoration of perfusion pressure may improve septic shock outcome."
        }, 
        "brief_title": "Early Use of Norepinephrine in Septic Shock Resuscitation", 
        "completion_date": {
            "#text": "August 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Septic Shock", 
            "Severe Sepsis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Toxemia", 
                "Shock", 
                "Shock, Septic"
            ]
        }, 
        "detailed_description": {
            "textblock": "We will include severe infection patient who had evidence of organ dysfunction and\n      hypotension and randomize into 2 groups as following:\n\n        1. Control group. The patient will receive treatment according to septic shock guideline\n           2013, which start with intravenous fluid replacement until achieve target central\n           venous pressure (CVP) or pulmonary capillary wedge pressure (PCWP) or other fluid\n           responsive test goal. If the patient's mean arterial blood pressure still lower than 65\n           mmHg, then norepinephrine or dopamine will initiate to rise blood pressure. The patient\n           will receive 5% dextrose water as the placebo of norepinephrine.\n\n        2. Early norepinephrine group. The patient will receive fluid therapy together with low\n           dose of norepinephrine (0.05 mcg/kg/min). If after titrate intravenous fluid therapy\n           until achieve goal CVP or PCWP or other fluid responsive test, but the mean blood\n           pressure still lower than 65 mmHg, then additional titrate dose of norepinephrine will\n           be given to the patient according to standard septic shock guideline."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > or = 18 years old\n\n          -  Diagnosed severe sepsis or septic shock according to survival sepsis campaign 2013\n\n          -  Mean arterial pressure < 65 mmHg\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Severe underlying condition that unexpected to survive more than 48 hours\n\n          -  Severe peripheral vascular disease\n\n          -  Patient who required major surgery within 24 hours"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01945983", 
            "org_study_id": "Si507/2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Early norepinephrine", 
                "description": "Initiation of norepinephrine, a strong vasoconstrictor, at the initiation of septic shock management, together with fluid resuscitation.", 
                "intervention_name": "Early norepinephrine", 
                "intervention_type": "Drug", 
                "other_name": "Early vasopressor therapy"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "5% dextrose water intravenous drip in the same rate of calculated norepinephrine for the patient's body weight", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "5%D/W infusion as the placebo of norepinephrine."
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Norepinephrine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Septic shock", 
            "Severe sepsis", 
            "Norepinephrine"
        ], 
        "lastchanged_date": "September 19, 2013", 
        "location": {
            "contact": {
                "email": "sicpk@mahidol.ac.th", 
                "last_name": "Chairat Permpikul, MD", 
                "phone": "0814081676"
            }, 
            "contact_backup": {
                "email": "tanuwongviarasilpa@hotmail.com", 
                "last_name": "Tanuwong Viarasilpa, MD", 
                "phone": "0813469400"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10700"
                }, 
                "name": "Siriraj Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Chairat Permpikul, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Tanuwong Viarasilpa, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Surat Tongyoo, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Comparison Between Early Norepinephrine Use and Standard Treatment During Severe Sepsis and Septic Shock Resuscitation.", 
        "other_outcome": {
            "description": "The days that patient can survive without vasopressor, ventilator support and renal replacement therapy.", 
            "measure": "Survive with organ support free days", 
            "safety_issue": "Yes", 
            "time_frame": "28 days"
        }, 
        "overall_official": {
            "affiliation": "Mahidol University", 
            "last_name": "Chairat Permpikul, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Therapeutic goal including\nMean arterial blood pressure > or = 65 mmHg\nEvidence of adequate tissue perfusion which include continuation of urine output > or = 0.5 ml/kg/hour for 2 hours or decreasing of serum lactate > or = 10 percent in 1 to 2 hours.", 
            "measure": "Therapeutic goal achievement", 
            "safety_issue": "Yes", 
            "time_frame": "6 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01945983"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "23353941", 
            "citation": "Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af."
        }, 
        "secondary_outcome": {
            "measure": "Mortality rate", 
            "safety_issue": "Yes", 
            "time_frame": "28 days"
        }, 
        "source": "Mahidol University", 
        "sponsors": {
            "collaborator": {
                "agency": "Siriraj Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Mahidol University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}